• Info
  • Social Media
  • Title

    BRCA1 & 2 Genes and the Risk of Breast Cancer

  • Summary

    The “breast cancer genes,” BRCA 1 and 2, may not be as imposing as they have been made to seem. Epigenetics maintains breast cancer is a result of attitude and outlook on life.

  • Press Release Video

    BRCA1 & 2 Genes and the Risk of Breast Cancer from prREACH on Vimeo.

  • Details

    (prREACH) The “breast cancer genes,” BRCA 1 and 2, may not be as imposing as they have been made to seem. Bruce Lipton, who advocates epigenetics, said breast cancer isn’t caused by one of two patented genes but rather is a result of attitude and outlook on life.
    Dr. Lipton, a developmental biologist and professor at the New Zealand College of Chiropractic, discusses this approach on BeWellBuzz’s Wellness Wednesdays.
    First, there’s some background to understand. In 1980, the Supreme Court ruled a company could patent any organism that was chemically altered otherwise created or altered or isolated from its naturally-occurring state by human hands.
    Myriad Genetics patented the isolated forms of two “breast cancer risk” genes, BRCA 1 in 1994 and BRCA 2 in 1995. Anyone wanting to test for BRCA 1&2 must go through a Myriad or Myriad-licensed lab, a 20-year restriction that ends next year and the year after.
    Lipton said the epigenetics approach would allow even those women carrying the genes to prevent them from being expressed as breast cancer, naturally and completely, without medical intervention such as Myriad Genetics’ patented tests.
    “The core tenets of epigenetics are empowerment and that all of our bodily functions are are all the result of the internal environment which we create, not genetic predispositions,” Lipton said.

  • Video
  • Links http://bewellbuzz.com
  • Images BRCA1 & 2 Genes and the Risk of Breast CancerMyriad Genetics patented the isolated forms of two “breast cancer risk” genes, BRCA 1 in 1994 and BRCA 2 in 1995.
  • Contact

    Larry Ostrovski

    702-513-4065

    http://bewellbuzz.com

  • Follow Us
  • Visit Site